Prelude Capital Management’s Cantel Medical Corporation CMD Stock Holding History

Prelude Capital Management’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,269	Closed	-$56K	–	2574
2020 Q2	$56K	Buy	+1,269	New	+$47.3K	﹤0.01%	1130
2018 Q3	–	Sell	-221	Closed	-$22K	–	2164
2018 Q2	$22K	Buy	+221	New	+$24.7K	﹤0.01%	1335
2015 Q3	–	Sell	-1,163	Closed	-$62K	–	1903
2015 Q2	$62K	Buy	+1,163	New	+$56.6K	0.01%	1078

Other funds holding CMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LGP

Leonard Green & Partners Los Angeles, California $2.77B AUM 3.28% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Prelude Capital Management's CMD Position: Q3 2020 in Review

Prelude Capital Management sold out of Cantel Medical Corporation (CMD) in Q3 2020, closing a stake of 1,269 shares — an estimated $56K sold.

Prelude Capital Management first reported a position in CMD in Q2 2015 and held it in 3 quarters. The position peaked at $62K in Q2 2015. 196 funds tracked by Wall St. Rank hold CMD as of Q3 2020.

Prelude Capital Management reported no remaining Cantel Medical Corporation position as of Q3 2020 after selling out during the quarter.
Prelude Capital Management sold 1,269 Cantel Medical Corporation shares in Q3 2020, an estimated $56K.
Prelude Capital Management first reported a position in Cantel Medical Corporation in Q2 2015 and held it in 3 quarters.
Prelude Capital Management's Cantel Medical Corporation position peaked at $62K in Q2 2015.
196 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q3 2020.

Based on Prelude Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.